US · Healthcare

Nutri Pharmaceuticals Research Inc (NRPR)

Health Information Services

Nutri Pharmaceuticals Research Inc (NRPR) is listed on US in the Healthcare sector. Industry: Health Information Services. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NRPR

P/E ratio

18.00

Nutri Pharmaceuticals Research Inc (NRPR) — FAQ

What is NRPR's P/E ratio?

The price-to-earnings (P/E) ratio for Nutri Pharmaceuticals Research Inc (NRPR) is 18.00 (data as of 2026-03-24).

Does Nutri Pharmaceuticals Research Inc pay a dividend?

Dividend yield is not available in the current snapshot for Nutri Pharmaceuticals Research Inc (NRPR). Check the MyAverix Finance app for the latest dividend data.

What sector is Nutri Pharmaceuticals Research Inc in?

Nutri Pharmaceuticals Research Inc (NRPR) is classified in the Healthcare sector (Health Information Services industry).

What exchange is NRPR listed on?

NRPR is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)